# US 2024/0002808 A1 · Complex Human Gut Microbiome Cultured In An Anaerobic Human Gut-On-A-Chip

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002808 A1
- Document ID: US20240002808A1
- Status: Published application
- Kind: A1
- Application number: 18/226,184
- Filed: 2023-07-25
- Published: 2024-01-04
- Earliest claimed: 2018-04-02
- Assignees: President and Fellows of Harvard College
- Applicants: President and Fellows of Harvard College
- Inventors: Richard Novak; Sasan Jalili-Firoozinezhad; Francesca S. Gazzaniga; Elizabeth Calamari; Diogo M. Camacho; Bret Andrew Nestor; Cicely Fadel; Michael J. Cronce; Dennis Kasper; Donald E. Ingber; Amir Bein
- Web page: https://patentgrep.com/patent/US20240002808A1

## CPC

- C12N 5/0679: {Cells of the gastro-intestinal tract}
- G01N 33/5082: {Supracellular entities, e.g. tissue, organisms}
- C12M 21/08: {for producing artificial tissue or for ex-vivo cultivation of tissue (prostheses A61F2/00, grafts A61L27/00)}
- C12M 23/16: {Microfluidic devices; Capillary tubes (integrated microfluidic structures B01L3/5027; microreactors B01J19/0093)}
- C12M 25/02: {Membranes; Filters (filters or filtration in general B01D24/00-B01D41/00)}
- C12M 29/04: {Filters; Permeable or porous membranes or plates, e.g. dialysis}
- C12N 1/20: Bacteria; Culture media therefor
- C12Q 1/02: involving viable microorganisms
- C12Q 1/10: Enterobacteria
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

A microfluidic device is directed to sustaining a complex microbial community in direct and indirect contact with living human intestinal cells in vitro. The device includes a first microchannel having cultured cells of a human intestinal epithelium and microbiota, the first microchannel further having a first level of oxygen. The device further includes a second microchannel having cultured cells of a vascular endothelium, the second microchannel further having a second level of oxygen. The device also includes a membrane located at an interface region between the first microchannel and the second microchannel, the membrane being composed of an oxygen-permeable material or further having pores via which oxygen flows between the first microchannel and the second microchannel to form a physiologically-relevant oxygen gradient.

## Claims

### Claim at position 1

1-147. (canceled)

### Claim 148

A method, comprising:
a) providing a microfluidic device, a source of microbes comprising living obligate anaerobes and living parenchyma cells; and
b) culturing the obligate anaerobes and the parenchyma cells in the microfluidic device such that at least a portion of the obligate anaerobes and at least a portion of the parenchyma cells are in direct contact.

### Claim 149 (depends on 148)

The method of claim 148, wherein the living obligate anaerobes are from the surface or contents of a body, orifice or cavity.

### Claim 150 (depends on 148)

The method of claim 148, wherein the parenchyma cells are human intestinal epithelial cells.

### Claim 151 (depends on 148)

The method of claim 148, wherein, after the culturing, unknown microbes are identified.

### Claim 152 (depends on 148)

The method of claim 148, wherein the culturing comprises flowing media at a flow rate.

### Claim 153 (depends on 148)

The method of claim 148, wherein the microfluidic device comprises a second microchannel positioned below a first microchannel and separated from the first microchannel by a membrane.

### Claim 154 (depends on 153)

The method of claim 153, wherein oxygenated medium flows through the second microchannel from external oxygenated medium reservoirs.

### Claim 155 (depends on 154)

The method of claim 154, wherein parenchyma cells in the first microchannel get oxygen from the second microchannel.

### Claim 156 (depends on 148)

The method of claim 148, wherein the culturing takes place for at least 2 days.

### Claim 157 (depends on 148)

The method of claim 148, wherein the culturing takes place for at least 3 days.

### Claim 158 (depends on 148)

The method of claim 148, wherein the culturing takes place for at least 5 days.

### Claim 159 (depends on 157)

The method of claim 157, wherein cultured microbiome comprises both anaerobic bacteria and aerobic bacteria.

### Claim 160 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises at least 2 anaerobic species found in the fecal sample.

### Claim 161 (depends on 157)

The method of claim 157, wherein the cultured microbiome comprises microbes from at least 2 genera found in the fecal sample.
